BCM has created a new technology to repair diseased, injured, or failing organs. The Autologous Regenerative Tissue Replacement (ARTR™) organ repair technology uses a special 5StageAutograft™ procedure to take a biopsy of healthy cells from the patient’s organ. These cells are used to grow many fully functioning mature, healthy cells. These newly grown and mature healthy cells are surgically inserted back into the patient’s organ where they integrate with the other cells and begin to rapidly multiply to regenerate the patient’s organ back to a healthy state.
This procedure’s five stages are defined by the process sequence which includes: Biopsy – Growth - Implant – Integrate - Outburst. All stages are performed upon the same, single patient over a 30 to 45-day period.
BCM has partnered with RTH Network to be the exclusive global distributor of ARTR™ products. RTH Network also administers the ARTR™ organ repair participating Evaluating Physicians and Operating Surgeons.
BCM is currently in clinical trials, addressing ARTR™ kidney organ repair. We are seeking interested participants. If you are interested or want to learn more, please visit the RTH Network website, and click on the Patient Join link.
BCM will soon commence clinical trials addressing ARTR™ liver, lungs, and pancreas organ repairs. This same technology and procedure will also be used to address cartilage, muscles, and bones regeneration and repairs in the near future.
For detailed information on this technology and procedure visit the RTH Network at: https://www.righttohealnetwork.com and click on the ARTR™ Information link.
With our successful development of advanced regenerative technologies, BCM Industries has emerged as the global leader in Autologous Regenerative Tissue Replacement organ repair.
Now addressing liver, kidneys, lungs, pancreas, skin, and soon muscles, cartilage, and bone.
Kidney ARTR Procedure - Biopsy Phase
Liver Repair Procedure
Introduction to Physicians and Hospitals
New Jersey Laboratory